enGene Holdings Target Price

Analysts' average 12-month price target for enGene Holdings is $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.83

Average Target Price

$3.00

63.9% upside

7 analysts in the last 4 months

High: $4 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-18	Morgan StanleyJudah Frommer	$3	63.9% upside
2026-06-16	H.C. WainwrightAndres Maldonado	$4	118.6% upside
2026-05-14	UBS	$2	9.3% upside
2026-05-08	Leerink PartnersMarket Perform	$2	9.3% upside
2026-05-08	Raymond James	$4	118.6% upside
2026-05-08	Piper SandlerAllison Bratzel	$4	118.6% upside
2026-05-08	Wells Fargo	$2	9.3% upside
2026-03-09	Raymond JamesSean McCutcheon	$27	1375.4% upside
2026-01-30	Jefferies	$28	1430.1% upside
2025-12-03	H.C. WainwrightAndres Maldonado	$25	1266.1% upside
2025-11-12	OppenheimerLeland Gershell	$33	1703.3% upside
2025-11-12	UBS	$10	446.4% upside
2024-11-18	JMP SecuritiesSilvan Tuerkcan	$18	883.6% upside
2024-09-27	Leerink PartnersMani Foroohar	$17	829% upside

enGene Holdings (ENGN) FAQ

As of the most recent data, ENGN shows a target price of $3. Scroll down for historical charts and peer comparison views.

If enGene Holdings moved to the average analyst target of $3, shares would be roughly 63.9% higher than $1.83. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of enGene Holdings's earnings trajectory.

Besides this target price page, Stockcircle has enGene Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $3) with ownership activity and broader fundamentals.